The Liver Cancer Collaborative brings together more than 50 researchers, clinicians and data specialists to revolutionise treatment for liver cancer through a clinician-led liver cancer biorepository integrated with extensive clinical, genomic and discovery research data.
The Leukemia & Lymphoma Society (LLS), transitioning to Blood Cancer United in August 2025, is a global nonprofit founded in 1949. It is dedicated to curing blood cancers and improving the quality of life for patients and their families. LLS is the largest voluntary health organization focused on blood cancer, having invested over $1.8 billion in research and serving a wide network of patients, caregivers, and healthcare professionals.
LLS's mission is to cure various blood cancers, including leukemia and lymphoma, while enhancing patient support. The organization is the largest nonprofit funder of blood cancer research, committing nearly $1.3 billion to advancements in immunotherapy and personalized medicine. LLS also provides free information, education, and support services to help patients navigate their diagnosis and treatment. Additionally, LLS advocates for improved access to care and increased research funding at both federal and state levels.